WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT

Por S. Yu. Martsevich, Y. V. Lukina
Publicado em 2017-11-01

Treatment Adherence to Drug Therapyin Patients with Stable Coronary Artery Disease During the COVID-19 Pandemic

Por S. Y. Martsevich, Y. V. Lukina, E. D. Zharkova, N. P. Kutishenko
Publicado em 2021-03-01

SCHOOL OF HEALTH FOR PATIENTS WITH CARDIO-VASCULAR DISEASES: BALANCE BETWEEN ANDRAGOGIC AND PEDAGOGIC EDUCATIONAL MODELS

Por S. K. Kukushkin, E. A. Poddubskaya, Y. V. Lukina, M. G. Bubnova
Publicado em 2016-01-01

THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER)

Por M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
Publicado em 2015-09-01

COMPARATIVE STUDY OF EFFICIENCY AND SAFETY OF THE NEW DRUG OF AMLODOPINE – S-AMLODOPINE IN PATIENTS WITH ARTERIAL HYPERTENSION OF I-II DEGREE

Por M. A. Maksimova, Y. V. Lukina, S. N. Tolpygina, E. V. Shilova, N. A. Dmitrieva, S. Y. Martsevich
Publicado em 2016-01-01

INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA

Por N. P. Kutishenko, N. A. Dmitrieva, Y. V. Lukina, M. P. Kozireva, Y. E. Semyonova, A. D. Deev, S. Y. Martsevich
Publicado em 2015-12-01